ANAPLASTIC LYMPHOMA KINASE

Approval Year

Substance Class	Protein Created by `admin` on `Tue Apr 01 23:38:34 GMT 2025` Edited by `admin` on `Tue Apr 01 23:38:34 GMT 2025`
Protein Sub Type
Sequence Type	COMPLETE
Record UNII	4M56WLI1MN
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

ANAPLASTIC LYMPHOMA KINASE

Common Name

English

CD-246

Preferred Name

English

ALK TYROSINE KINASE RECEPTOR

Systematic Name

English

ALK

Common Name

English

CD246

Code

English

Code System Code Type Description

FDA UNII

4M56WLI1MN

Created by admin on Tue Apr 01 23:38:34 GMT 2025 , Edited by admin on Tue Apr 01 23:38:34 GMT 2025

PRIMARY

WIKIPEDIA

ANAPLASTIC LYMPHOMA KINASE

Created by admin on Tue Apr 01 23:38:34 GMT 2025 , Edited by admin on Tue Apr 01 23:38:34 GMT 2025

PRIMARY

UNIPROT

Q9UM73

Created by admin on Tue Apr 01 23:38:34 GMT 2025 , Edited by admin on Tue Apr 01 23:38:34 GMT 2025

PRIMARY

Glycosylation Type

HUMAN

Glycosylation Link Type	Site
N	1_151
N	1_226
N	1_267
N	1_306
N	1_393
N	1_406
N	1_427
N	1_545
N	1_553
N	1_609
N	1_691
N	1_790
N	1_845
N	1_846
N	1_868
N	1_968

Related Record Type Details


					7DR7JMB8BH

X-376

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					J8AY0Z4CBP

CEP-11981

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					6L7WLR552I

5H-BENZO(B)CARBAZOLE-3-CARBONITRILE, 9-ETHYL-6,11-DIHYDRO-8-(4-((2-HYDROXYETHYL)AMINO)-1-PIPERIDINYL)-6,6-DIMETHYL-11-OXO-

INHIBITOR -> TARGET

Qualification:

IC50

Amount:


					HYW8DB273J

BRIGATINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					QB7KTQ7VW9

ENVONALKIB

INHIBITOR -> TARGET

Amount:


					HP4L6MXF10

ASP-3026

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					08O3FQ4UNP

REPOTRECTINIB

INHIBITOR -> TARGET


					53AH36668S

Crizotinib

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					SMA5ZS5B22

ENSARTINIB

INHIBITOR -> TARGET

Amount:


					Z8A6022P3J

BELIZATINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					K418KG2GET

CERITINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					L5ORF0AN1I

ENTRECTINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					O3MNS8782H

CEP-37440

INHIBITOR -> TARGET


					4T3Z98RR86

Unecritinib

INHIBITOR -> TARGET

Amount:


					5BKJ4Z6RBU

Zotizalkib

INHIBITOR -> TARGET

Interaction Type:

IN-VITRO, IN-VIVO

Amount:


					LIJ4CT1Z3Y

ALECTINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					2FH56C28YT

Dirozalkib

INHIBITOR -> TARGET

Amount:


					OSP71S83EU

LORLATINIB

INHIBITOR -> TARGET

Interaction Type:

INHIBITOR

Qualification:

IC50

Amount:


					Z5F65W1YAZ

IRUPLINALKIB

INHIBITOR -> TARGET

Qualification:

IC50

Amount:

Structural Modifications

Modification Type	Location Site	Location Type	Residue Modified	Extent	Fragment Name	Fragment Approval
AMINO ACID SUBSTITUTION	[1_1060] [1_1074] [1_1078] [1_1113] [1_1260] [1_1489] [1_1586]				TYROSINE O-PHOSPHATE	2R86C98KDX

Name	Property Type	Amount	Referenced Substance	Defining	Parameters	References
MOL_WEIGHT	CHEMICAL